Fluorothiazinone

Fluorothiazinone (CL-55, Ftortiazinon, Фтортиазинон) is an antibiotic drug, first developed in Russia in 2010 and active against various species of Gram-negative bacteria through inhibition of the type III secretion system (T3SS). It has seen limited clinical use in Russia and is in clinical trials which may eventually see it accepted for use more widely.^{[1][2][3][4][5][6][7][8][9][10]}

Fluorothiazinone

Legal status
Legal status	Investigational
Identifiers
IUPAC name N-(2,4-difluorophenyl)-4-[(3-ethoxy-4-hydroxyphenyl)methyl]-5-oxo-1,3,4-thiadiazine-2-carboxamide
CAS Number	1370706-59-4
PubChem CID	132512026
ChemSpider	88296074
Chemical and physical data
Formula	C19H17F2N3O4S
Molar mass	421.42 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCOC1=C(C=CC(=C1)CN2C(=O)CSC(=N2)C(=O)NC3=C(C=C(C=C3)F)F)O
InChI InChI=1S/C19H17F2N3O4S/c1-2-28-16-7-11(3-6-15(16)25)9-24-17(26)10-29-19(23-24)18(27)22-14-5-4-12(20)8-13(14)21/h3-8,25H,2,9-10H2,1H3,(H,22,27) Key:DAKWAZGLXWXDBB-UHFFFAOYSA-N

See also

• List of Russian drugs
• Aurodox
• Triazavirin